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Increased Risks of Upper Tract Urothelial Carcinoma
in Male and Female Chinese Herbalists
Hsiao-Yu Yang,1,2,3 Jung-Der Wang,1,4,6 Tsai-Chang Lo,5 Pau-Chung Chen1,4*
Background/Purpose: It has been shown that herbs that contain aristolochic acid induce urological cancer.
Chinese herbalists have easy access to such herbs. Our previous mortality study has shown a significantly
increased risk of urological cancer in female but not male herbalists. To re-examine this risk in male
herbalists, the incidence of urological cancer was analyzed.
Methods: We enrolled all 6550 Chinese herbalists in Taiwan registered during 1985–2000, and we retro-
spectively followed the development of cancer until 2001 by analysis of data collected from the Taiwan
Cancer Registry. Standardized incidence ratios (SIRs) were calculated for urological cancers in herbalists
and compared with those for the general population in Taiwan.
Results: There were 30 newly diagnosed cases of urological cancer and most of them were transitional cell
carcinoma (93.1%). The mean age at diagnosis for urothelial carcinoma was 51.6 years, and 51.9% were in
the upper urinary tract. After adjustment for age and sex, the SIR for all urological cancers was 3.51 [(95%
confidence interval (CI): 2.37–5.01]. When stratified by location, the SIRs for kidney and upper urinary
tract cancers and bladder cancer were 4.24 (95% CI: 2.47–6.80) and 2.86 (95% CI: 1.52–4.89), respec-
tively. When analyzed by sex, the SIRs for all urological cancers, kidney and upper urinary tract cancers,
and bladder cancer were also significantly increased in male herbalists.
Conclusion: The significant risk of urothelial carcinoma noted in male herbalists increases our suspicion
that this is an occupational disease that renders regular health assessment of herbalists an urgent necessity.
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Herbs have been used extensively throughout the
world and during human history.1 Chinese herbal
drugs are not only used in China, but also in
Taiwan, Korea, Japan and Hong Kong.2–5 An 
important reason for such extensive usage is that
people believe herbal drugs are mild and harm-
less.6 In Taiwan, Chinese medicine is covered 
by National Health Insurance, which regularly
reimburses the costs of Chinese herbal products.7,8
In 1993, Vanherweghem and his colleagues first
reported that many young women who took
Chinese herbs that contained aristolochic acid
(AA) developed renal failure and urothelial car-
cinoma.9 AA has been found in many Chinese
herbs.10–13 Although nephropathy and urothelial
carcinoma related to the use of herbs have been
reported in Belgium, Hong Kong, China and
Taiwan,9,14–17 the occupational risks in Chinese
herbalists have rarely been studied.18 Herbal medi-
cine is an ancient form of healing in Chinese 
society. Herbalists are not formally educated or
trained in conventional medical or pharmacy
schools. Instead, the knowledge of Chinese medi-
cine is passed down from generation to generation
by the “master and apprentice” system. Herbalists
as an occupational group have the greatest access
to Chinese herbs.19
Our previous studies based on analysis of
data from the Taiwan National Mortality Registry
Database have found that female herbalists have
a higher mortality risk of urological cancer and
chronic kidney diseases. However, in male herbal-
ists, the increased risk is only significant for chro-
nic kidney disease and not for urological cancer.18
The mortality rate is associated with the quality
of the health care system, and patients with uro-
logical cancer have an 11-year life expectancy in
Taiwan.20 Patients possibly die from causes other
than urological cancer (not mentioned in the
mortality registry, which, in addition, does not
contain pathology reports), therefore, the use of
these registers in our previous study might have
led to underestimation of the risk of urothelial
malignancy in male herbalists.
To examine whether the risk of urological cancer
is increased in male Chinese herbalists, this study
analyzed data from the National Cancer Registry.
Material and Methods
Participants
In Taiwan, the Labor Insurance Program began in
1960 and all workers aged 15–60 years are required
to join. The Chinese Herbalist Union was estab-
lished in 1985, and most herbalists in Taiwan
who work in traditional Chinese herbal stores are
members. In this study, we enrolled all Chinese
Herbalist Union members who were insured under
the Labor Insurance Program between 1985 and
2000. Date of birth, sex and employment history
were obtained from the Bureau of Labor Insurance
database. Any case of missing data or coding error,
such as cancer diagnosis earlier than the date 
of first employment, was excluded from further
analysis.
Some herbalists might have started to work in
herbal stores before 1985 and many had begun to
work after they completed their 9-year elementary
school education, or were 15 years old; therefore,
we defined the start of occupational exposure to
herbs as age 15 years, and the end of exposure as
the date of departure from the union, occurrence
of cancer, or the end of the observation period.
The occurrence of cancer, date of diagnosis,
histological pattern and cancer site coded in the
International Classification of Diseases (ICD)-9
were obtained from the Taiwan Cancer Registry.
The registry is a population-based cancer registry
established in 1979 and funded by the Department
of Health. Hospitals with more than 50-bed capac-
ity that provide outpatient and hospitalized cancer
care are expected to report all newly diagnosed
malignant neoplasms to the registry.21 For com-
parability, we converted all the ICD-9 diagnosis
codes to ICD-10 codes.22 We followed the devel-
opment of cancer to the end of 2001. The study
protocol was approved by the Ethics Committee
of the National Taiwan University College of
Public Health before commencement.
Statistical analysis
We used the Life Table Analysis System for
Personal Computers22 version 1.0d, developed
by the National Institute for Occupational Safety
and Health, to calculate (via indirect standardi-
zation methods) the standardized incidence ratio
(SIR) for each cancer. The observed number of
cancers was compared with the expected number
within every 5-year stratum. The expected number
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was computed by multiplying the sex-, age- and
calendar-time-specific reference rates of the gen-
eral population in Taiwan by the observed person–
years at risk in each stratum. The total observed
and expected numbers of cancers were calculated
by summing the numbers in all strata. The SIR
was calculated by dividing the total observed can-
cers (in the numerator) by total expected cancers
(in the denominator).
The 95% confidence interval (CI) and two-
tailed p values were calculated under the assump-
tion that the observed cancers followed a Poisson
distribution. We assumed that an exposure re-
quired a minimum induction period before it
could cause cancer, and set lag periods to prevent
recent exposure contributing to the cumulative
level of exposure. By calculation of the incidence
rate of cancer, exposure periods that occurred
within the lag period were not accumulated into
the person–years at risk, and cancers that occurred
within the lag period were grouped into a non-
occupational exposure to herbs group.22 The urolo-
gical cancers progressed for 3–15 years depending
on the cumulative dose of AA.23,24 Under the as-
sumption that herbalists might have had chronic
and low-dose exposure to herbs that contained
AA, sensitivity analysis with 10- and 15-year lag
periods was performed to calculate the SIR for
urological cancers. In this study, urological can-
cer included malignant neoplasm of the bladder
(ICD-9: 188), kidney and other unspecified uri-
nary organs (ICD-9: 189). The SIR for malignant
neoplasm of the prostate (ICD-9: 185) was calcu-
lated separately and was not included in urologi-
cal cancer.
Results
The cohort consisted of 6555 Chinese herbalists.
After excluding five herbalists with missing em-
ployment data, we finally enrolled 6550 herbal-
ists (3093 men and 3457 women) for analysis. 
A total of 59,856 male and 65,591 female person–
years were accrued during the observation period.
Among the 203 newly diagnosed cases of cancer
in the follow-up period, 30 were urological can-
cers. A positive association between exposure 
duration and the risk of urological cancer was 
illustrated by the trend of increased incidence
rate of urological cancer for longer exposure du-
ration, as shown in the Figure. After controlling
for the confounding effect of age by adjustment
to the sex-, age- and calendar-time-specific refer-
ence rates of the general population, the SIR was
still significantly higher for all urological cancers
(3.51, 95% CI: 2.37–5.01) in herbalists. When we
further stratified urological cancers by location,
the SIR for kidney and upper urinary tract cancers
(4.24, 95% CI: 2.47–6.80) was higher than that
for bladder cancer (2.86, 95% CI: 1.52–4.89). If
we stratified by sex, the SIRs for all urological
cancers, kidney and upper urinary tract cancers, or
bladder cancer were all significantly increased in
male herbalists, with a 10-year lag period. With a
15-year lag period, male herbalists also had sig-
nificantly elevated SIRs for all urological cancers,
or kidney and upper urinary tract cancers. The
SIRs for all urological cancers, kidney and upper
urinary tract cancers, or bladder cancer in female
herbalists, with 10- and 15-year lag periods, were
all significantly increased and higher than those
in male herbalists, as summarized in Table 2.
Among cases of urological cancers, most of them
were, histologically, transitional cell carcinoma
(93.1%). The mean age at diagnosis for urothelial
carcinoma was 51.6 years, and approximately half
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Figure. Incidence rate of urological cancer stratified by ex-
posure duration. A positive association is shown between
exposure duration and risk of urological cancer.
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of urothelial carcinomas (51.9%) were in the upper
urinary tract (Table 3).
Discussion
The role of Chinese herbal drugs in the patho-
genesis of kidney disease and urological cancer
has attracted much interest in recent years, and
virtually nothing is known about the health risks
for workers who are chronically exposed to them.
Consistent with our observation that male herbal-
ists have a high occupational exposure to herbs
that contain AA, this study provided evidence
that male herbalists had an increased risk of upper
urinary tract urothelial carcinoma, and showed
that changing the lag period did not change the
risk estimates (Tables 1 and 2).
Yet, we must rule out other alternative expla-
nations before proposing any new hypothesis.
Cigarette smoking is a major risk factor for
urothelial carcinoma.25 However, the prevalence
of cigarette smoking was much lower in herbal-
ists (17.1%) than in other Taiwanese workers
(26.7%).26,27 Thus, we believe that smoking is
not the responsible agent. Long-term use of anal-
gesics is another important risk factor.28 Based
on deeply rooted beliefs in the efficacy of Chinese
medicine, herbalists do not typically prescribe
western medicines, except in cases of severe ill-
ness. Indeed, only 2.9% of herbalists have reported
chronic use of analgesics,26 in comparison with
7.28% among the general population in Taiwan
who have been prescribed with more than 501
tablets of non-steroidal anti-inflammatory drugs
during 1997–2002, based on the reimbursement
database of National Health Insurance.29 Use of
analgesics cannot therefore account for the in-
creased risk in herbalists. Arsenic is a carcinogen
that is associated with urological cancer, and its
concentration is known to be high in artesian well
water from some areas where black-foot disease
is endemic.30,31 We checked the addresses of indi-
viduals with urological cancer, and none of them
Table 1. Standardized incidence ratio for different types of cancer in Chinese herbalists
Cancer site (ICD-10) Observed, n Expected, na SIR (95% CI)
All cancers 203 236.06 0.86b (0.75–0.99)
Nasopharynx (C11) 15 12.29 1.22 (0.68–2.01)
Esophagus (C15) 3 3.95 0.76 (0.16–2.22)
Stomach (C16) 9 13.26 0.68 (0.31–1.29)
Colon and rectum (C18–21) 13 22.76 0.57b (0.30–0.98)
Liver and intrahepatic bile ducts (C22) 21 31.04 0.68 (0.42–1.03)
Pancreas (C25) 6 2.63 2.28 (0.83–4.97)
Larynx (C32) 2 1.72 1.16 (0.14–4.19)
Trachea, bronchus, and lung (C33–34) 13 18.63 0.70 (0.37–1.19)
Breast (C50) 24 25.92 0.93 (0.59–1.38)
Urinary organs (C64–68) 30 8.55 3.51c (2.37–5.01)
Kidney and upper urinary tract (C64–66, C68) 17 4.00 4.24c (2.47–6.80)
Bladder (C67) 13 4.55 2.86c (1.52–4.89)
Eye (C69) 2 0.23 8.53b (1.03–30.79)
Brain (C71) 1 2.67 0.37 (0.01–2.08)
Other parts of nervous system (C70, C72) 1 0.27 3.37 (0.09–20.73)
Thyroid gland (C73) 4 5.52 0.73 (0.20–1.85)
Connective tissue (C46.1, C49) 1 1.43 0.70 (0.02–3.88)
Leukemia and aleukemia (C91.0–91.3, 4 5.05 0.79 (0.22–2.02)
C91.5–91.9, C92–95)
aThe expected number of cancer patients was calculated based upon the age and calendar-year-specific incidence rates of the general
population of Taiwan, with a 10-year lag period; btwo-tailed p<0.05; ctwo-tailed p<0.01. ICD-10= International Classification of
Diseases, 10th Revision; SIR= standardized incidence ratio; CI= confidence interval.
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lived in the regions with contaminated artesian-
well water. Thus, drinking arsenic-contaminated
water is probably not related to the increased risk.
As summarized in Table 3, urological cancers
among herbalists (compared with the general
population of Taiwan) are mainly transitional cell
carcinoma, and more likely to occur in the upper
urinary tract. The histological pattern and location
are similar to AA-related urological cancers reported
in Belgium, and are different from the urological
cancers (in general) reported in Taiwan.9,24,32 AA
is derived from extracts of Aristolochia, Bragantia
and Asarum species, and is a common ingredient
in many Chinese herbs, such as Madouling
(Aristolochia debilis), Tianxianteng (Aristolochia
contorta), Qingmuxiang (Aristolochia cucurbitifolia),
Guangfangji (Aristolochia fangji), Guanmutong
(Aristolochia manshuriensis), and Xixin (Radix et
Rhizoma Asari).10–13 The histological pattern and
location of the urological cancers in our sample
were similar to those of AA-related urological can-
cers; therefore, we postulate that the increased
risk among herbalists might be related to their
chronic exposure to Chinese herbs, which some-
times contain AA.
Based on our survey of herbalists in many 
traditional Chinese herbal stores, we suspect two
possible exposure routes. (1) Ingestion of herbal
Table 2. Standardized incidence ratio for urological cancers, stratified by sex and different lag periods
Cancer site (ICD-10)
10-year lag 15-year lag
n SIR (95% CI) n SIR (95% CI)
Male
All urinary organs (C64–68) 14 2.45a (1.34–4.10) 14 2.47a (1.35–4.14)
Kidney & upper urinary tract (C64–66, C68) 7 2.96a (1.19–6.11) 7 2.99a (1.20–6.17)
Bladder (C67) 7 2.08 (0.83–4.29) 7 2.10 (0.84–4.33)
Female
All urinary organs (C64–68) 16 5.66a (3.23–9.19) 15 5.39a (3.01–8.89)
Kidney & upper urinary tract (C64–66, C68) 10 6.09a (2.91–11.19) 9 5.58a (2.55–10.59)
Bladder (C67) 6 5.06a (1.85–11.02) 6 5.13a (1.87–11.16)
aTwo-tailed p<0.01. ICD-10= International Classification of Diseases, 10th Revision; n= observed numbers of cancer patients; 
SIR= standardized incidence ratio; CI= confidence interval.
Table 3. Comparison with urological cancers classified by location and histological patternsa
Urological cancers Urological cancers Urological cancers 
in herbalistsb in Belgian cohortc in Taiwan reported in 2004d
(n=30) (n=38) (n=3541)
Location
Kidney parenchyma 3 (10.0) 0 628 (17.7)
Pelvis and ureter 14 (46.7) 17 (44.7) 1055 (29.8)
Bladder 13 (43.3) 15 (39.5) 1858 (52.5)
Histological group
Renal cell carcinoma 2 (6.9) 0 502 (14.8)
Transitional cell carcinoma 27 (93.1) 32 (100) 2654 (78.4)
Adenocarcinoma – 0 70 (2.1)
Squamous cell carcinoma – 0 46 (1.4)
Others – 0 113 (3.3)
aData presented as n (%); bone case of urological cancer had no microscopic confirmation and was excluded from analysis; creference
24; dreference 32.
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powders or powder-contaminated food. Tradi-
tional Chinese herbal stores are usually small 
enterprises. In the past, workers usually participate
in all procedures (cutting, drying, grinding, pro-
cessing and packing), all of which generate lots of
dust. Herbal powders may be inhaled, deposited in
the oral pharynx, and then swallowed. Moreover,
herbalists usually work and live in herbal stores.
Many of their activities are performed in the back-
yard and there is no distinction between the din-
ing room and workplace; therefore, food might
be contaminated by herbal powders. (2) Habitual
use of herbal drugs. Herbalists generally prefer to
use herbal drugs for treating all illnesses, because
they are considered natural, mild and harmless.
To promote the Yin–Yang balance according to
the theory of Chinese medicine,33–35 many herbal-
ists also take daily herbal tonics to improve their
state of well-being. Therefore, the use of herbal
drugs is more prevalent in herbalists than in the
general population.19 In 2003, the Committee on
Chinese Medicine and Pharmacy of the Depart-
ment of Health issued a regulation prohibiting
the use of herbal drugs that contained Madouling,
Tianxianteng, Qingmuxiang, Guangfangji and
Guanmutong. However, earlier exposure to herbal
drugs that contain AA might account for the 
increased risk of urological cancer observed in
herbalists.
Some people suggest that herbalists might have
started their work with herbs before 1985, when
the Chinese Herbalist Union was not established,
and traditional herbal stores are usually family
owned businesses, thus many herbalists might
come into contact with herbs as children. Thus,
the actual person–years at risk might be greater
than the number reported. However, if we had
obtained earlier employment data and extended
the observation period, the number of cases re-
ported and person–years at risk would simulta-
neously have become larger. The risk of exposure
to herbs that probably contained AA did not
change substantially before 2003; therefore, the
estimates of SIR would not have differed signifi-
cantly before and after 1985. Another potential
confounder is the possibility that cases of
urological cancer existed at the time when the
herbalists joined the union and were insured.
However, the estimates were not affected by set-
ting a lag period (10 and 15 years; Table 2), and
suggested that the factor was not a confounder,
even though some subjects in this cohort might
be the family members and did not actually
worked in herbal stores and have another or no
job. However, they live in herbal stores and con-
sequently might also have been exposed to
herbal dusts. We think that this potential limita-
tion in classification had no effect on our results.
Chinese herbal drugs have been widely used in
Taiwan, with 39.3% of the general population
having been prescribed AA-containing Chinese
herbal products;36 therefore, many Taiwanese peo-
ple (categorized as non-exposed) could have
been exposed to AA. This potential misclassifica-
tion might have resulted in an underestimate of
the SIRs for urological cancers in our study. Thus,
the actual risk in Chinese herbalists might be
greater than our estimate.
This study showed that the risk of urological
cancers was higher in female than male herbalists.
In the Belgian cohort, all patients with AA-related
urothelial carcinoma were women who followed
herbal slimming regimens.23,24 Our other national
survey that used National Health Insurance data
from 1997 to 2003 found that most patients that
took AA-containing Chinese herbal products were
female.36 Similar findings in a medical center in
China have shown that the majority of renal trans-
plant recipients with urothelial carcinoma, who
had a history of taking AA-containing Chinese
herbs, were female.17 These findings all indicate
that the more frequent use of herbs in women
might be the cause of higher risk. However, in the
endemic of the Balkan Peninsula, residents ate
bread contaminated by AA and then developed
upper tract urothelial carcinoma, and women had
a higher risk than men.37–39 Our other retrospec-
tive study in Taiwan also has found that young
women are more likely to develop chronic kid-
ney disease if they consume more than the thres-
hold cumulative dose of herbs that contain AA.29
Therefore, we cannot rule out the possibility that
Urothelial carcinoma in herbalists
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women are more susceptible to AA-related renal
damage, and the alternative explanation could
explain why female herbalists have a higher risk of
urological cancers than their male counterparts,
who theoretically have higher occupational expo-
sure to herbs that contain AA. We recommend 
a future study to clarify this.
Some potential limitations of this study are
inherent in retrospective cohort studies. In Taiwan,
raw Chinese herbs are mostly imported from main-
land China, and many Chinese herbs from China
are reported to be contaminated by heavy metals,
including arsenic.19,40–44 We cannot rule out the
possibility that arsenic contamination plays a role
in the increased risk of urological cancer among
herbalists. Moreover, our study used the length of
employment as a surrogate for the degree of expo-
sure to herbs. Thus, more epidemiological data on
occupational exposure, environmental exposure,
lifestyle and medical history are needed to clarify
causality.
Since 2003, the Committee on Chinese
Medicine and Pharmacy has prohibited the use
of Madouling, Tianxianteng, Qingmuxiang,
Guangfangji and Guanmutong, and herbalists are
becoming aware of the hazards of AA. Moreover,
the procedures for manufacturing and process-
ing herbs have been shifted to mainland China
during the present decade. According to our in-
terview survey, most herbal stores do not now
process herbs, but only sell herbal products. We
suspect the incidence of urological cancer among
herbalists will decrease gradually in the next decade
because cancer might develop for several years
after discontinuation of exposure. Though the 
incidence of upper tract urothelial carcinoma in
Taiwan between 1998 and 2002 is higher than
the incidence in five continents after adjusted 
to age.21 This study used the general population
in Taiwan as reference population and the  stan-
dardized incidence ratio suggested an increased
risk in Chinese herbalists. Stricter prohibition,
including all herbs contaminated with AA, is
warranted to cease this trend.
In conclusion, the significant risk of urothe-
lial carcinoma noted in male herbalists increases
our suspicion that urothelial carcinoma is an 
occupational disease that renders regular health
assessment of herbalists an urgent necessity.
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